Kounis syndrome (allergic angina and allergic myocardial infarction): A natural paradigm?

Kounis, 1991, Histamine-induced coronary artery spasm: the concept of allergic angina, Br J Clin Pract, 45, 121, 10.1111/j.1742-1241.1991.tb10251.x Zosin, 1965, Allergic myocardial infarction, Rom Med Review, 19, 26 Kounis, 1996, Allergic angina and allergic myocardial infarction, Circulation, 94, 1789 Kounis, 1999, Unstable angina, allergic angina and allergic myocardial infarction, Circulation, 100, e156, 10.1161/01.CIR.100.25.e156 Constantinides, 1995, Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction, Circulatory, 92, 1083, 10.1161/01.CIR.92.5.1083 Brawnvald, 1998, Unstable angina. An etiologic approach to management, Circulation, 98, 2219, 10.1161/01.CIR.98.21.2219 Zavras, 2003, Kounis syndrome secondary to allergic reaction following shellfish ingestion, Int J Clin Pract, 57, 622, 10.1111/j.1742-1241.2003.tb10570.x Koutsojannis, 2004, Lepirudin anaphylaxis and Kounis syndrome, Circulation, 109, e315, 10.1161/01.CIR.0000129324.33507.DC Koutsojannis, 2004, Corticosteroids, Kounis syndrome and the treatment of refractory vasospastic angina, Circulation J, 68, 806, 10.1253/circj.68.806 Mallioris, 2004, Glucocorticoids, Kounis syndrome and the prevention of atrial fibrillation, Eur Heart J, 25, 2175, 10.1016/j.ehj.2004.08.014 Kounis, 2005, Myocardial infarction after aspirin, and Kounis syndrome, J R Soc Med, 98, 296, 10.1258/jrsm.98.6.296-a Mazarakis, 2005, Cefuroxime-induced coronary artery spasm manifesting as Kounis syndrome, Acta Cardiol, 60, 341, 10.2143/AC.60.3.2005015 Soufras, 2005, Penicillin allergy in cancer patients manifesting as Kounis syndrome, Heart Vessels, 20, 159, 10.1007/s00380-004-0804-6 Waller, 2004, Non atherosclerotic coronary heart disease, 1183 Nikolaidis, 2002, Allergic angina and allergic myocardial infarction: a new twist on an old syndrome, Can J Cardiol, 18, 508 Galli, 2005, Mast cells in the development of adaptive immune responses, Nat Immunol, 6, 135, 10.1038/ni1158 Galli, 2005, Mast cells as “tunable” effector and immunoregulatory cells: recent advances, Annu Rev Immunol, 23, 749, 10.1146/annurev.immunol.21.120601.141025 Ishizaka, 1984, Activation of mast cells for mediator release through IgE receptors, Prog Allergy, 34, 188 Liu, 1986, Human lung macrophage-derived histamine-releasing activity is due to IgE-depended factors, J Immunol, 136, 2588, 10.4049/jimmunol.136.7.2588 Sedgwick, 1981, Production of a histamine-releasing lymphokine by antigen- or mitogen-stimulated human peripheral T cells, Clin Exp Immunol, 45, 409 Metcalfe, 1981, The mast cell, Crit Rev Immunol, 3, 23 McCurdy, 2003, Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells, J Immunol, 170, 1625, 10.4049/jimmunol.170.4.1625 Barke, 1993, Opiates, mast cells and histamine release, Life Sci, 53, 1391, 10.1016/0024-3205(93)90581-M Di Lorenzo, 2002, Urinary metabolites of histamine and leukotrienes before and after placebo-controlled challenge with ASA and food additives in chronic urticaria patients, Allergy, 57, 1180, 10.1034/j.1398-9995.2002.23767.x Murray, 2004, Endothelin-1 mediates cardiac mast cell degranulation, matrix metalloproteinase activation, and myocardial remodeling in rats, Am J Physiol Heart Circ Physiol, 287, H2295, 10.1152/ajpheart.00048.2004 Lindstedt, 2004, Mast cells in vulnerable coronary plaques: potential mechanisms linking mast cell activation to plaque erosion and rupture, Curr Opin Lipidol, 15, 567, 10.1097/00041433-200410000-00011 Dvorak, 1992, Basophils and mast cells: piecemeal degranulation in situ and ex vivo: a possible mechanism for cytokine-induced function in disease, Immunol Ser, 57, 169 van Haaster, 1995, Differential release of histamine and prostaglandin D2 in rat peritonal mast cells; roles of cytosolic calcium and protein tyrosine kinases, Biochim Biophys Acta, 1265, 79, 10.1016/0167-4889(94)00210-6 Gagari, 1997, Differential release of mast cell interleukin-6 via c-kit, Blood, 89, 2654, 10.1182/blood.V89.8.2654 Kandere-Grzybowska, 2003, Interleukin-1-induced secretion of interleukin-6 without degranulation from human mast cells, J Immunol, 171, 4830, 10.4049/jimmunol.171.9.4830 Silver, 2004, Mast cells: a unique source of rennin, Proc Natl Acad Sci U S A, 101, 13607, 10.1073/pnas.0403208101 Hara, 2004, Preformed angiotensin II is present in human mast cells, Cardiovasc Drugs Ther, 18, 415, 10.1007/s10557-004-6218-y Genovese, 1997, Highlights in cardiovascular effects of histamine and H1-receptor antagonists, Allergy, 52, 67, 10.1111/j.1398-9995.1997.tb04813.x Christian, 1989, Endogenous histamine excites neurones in guinea-pig superior cervical ganglion in vitro, J Physiol, 409, 297, 10.1113/jphysiol.1989.sp017498 Laine, 2000, Adventitial mast cells connect with sensory nerve fibers in atherosclerotic coronary arteries, Circulation, 101, 1665, 10.1161/01.CIR.101.14.1665 Masini, 1998, The role of histamine in platelet aggregation by physiological and immunological stimuli, Inflamm Res, 47, 211, 10.1007/s000110050319 Saxena, 1989, Histamine is an intracellular mediating platelet aggregation, Science, 243, 1596, 10.1126/science.2928797 Shah, 2000, Synergistic interaction of adrenaline and histamine in human platelet aggregation is mediated through activation of phospholipase, nap kinase and cyclo-oxygenase pathways, Pharmacol Res, 42, 479, 10.1006/phrs.2000.0721 Benbarek, 1999, High concentrations of histamine stimulates equine polymorphonuclear neutrophils to produce reactive oxygen species, Inflamm Res, 48, 594, 10.1007/s000110050509 Elenkov, 1998, Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors, J Immunol, 161, 2586, 10.4049/jimmunol.161.5.2586 Clark, 1977, Histamine modulation of eosinophil migration, J Immunol, 118, 137, 10.4049/jimmunol.118.1.137 Li, 2001, Histamine induced production of interleukin-6 and interleukin-8 by human coronary artery endothelial cells is enhanced by endotoxin and tumor necrosis factor-alpha, Microvasc Res, 61, 253, 10.1006/mvre.2001.2304 Asako, 1994, Role of H1 receptors and P-selectin in histamine-induced leucocyte rolling and adhesion in post capillary venules, J Clin Inest, 93, 1508, 10.1172/JCI117129 Eppihimer, 1996, Heterogenicity of expression of E- and P-selectins in vivo, Circ Res, 79, 560, 10.1161/01.RES.79.3.560 Miyazawa, 1998, Role of histamine H1 and H2 receptor antagonists in the prevention of intimal thichening, Eur J Pharmacol, 362, 53, 10.1016/S0014-2999(98)00716-X Huang, 2002, Acute stress induces cardiac mast cell activation and histamine release, effects that are increased in Apolipoprotein E knockout mice, Cardiovasc Res, 55, 150, 10.1016/S0008-6363(02)00336-X Pang, 1988, A neurotensin receptor antagonist inhibits acute immobilization stress-induced cardiac mast cell degranulation, a corticotropin-releasing hormone-dependent process, J Pharmacol Exp Ther, 287, 307 Theoharides, 2004, Mast cells as targets of corticotropin-releasing factor and related peptides, Trends Pharmacol Sci, 25, 563, 10.1016/j.tips.2004.09.007 Cao, 2005, Human mast cells express corticotropin-releasing hormone(CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor, J Immunol, 174, 7665, 10.4049/jimmunol.174.12.7665 Steffel, 2005, Histamine induces tissue factor expression. Implications for acute coronary syndromes, Circulation, 112, 341, 10.1161/CIRCULATIONAHA.105.553735 Moons, 2002, Tissue factor and coronary artery disease, Cardiovasc Res, 53, 313, 10.1016/S0008-6363(01)00452-7 Johnson, 1998, Activation of matrix-degrating metalloproteinases by mast cell proteases in atherosclerotic plaques, Arterioscler Thromb Vasc Biol, 18, 707, 10.1161/01.ATV.18.11.1707 Laine, 1999, Association between myocardial infarction and mast cells in the adventitia of the infarct-related coronary artery, Circulation, 99, 361, 10.1161/01.CIR.99.3.361 Tselepis, 1999, Platelet aggregatory response to platelet activating factor (PAF), ex vive, and PAF-acetylhydrolase activity in patients with unstable angina: effect of c7E3 (abciximab) therapy, Cardiovasc Res, 43, 183, 10.1016/S0008-6363(99)00078-4 Carry, 1992, Increased urinary leucotriene excretion in patients with cardiac ischemia: in vivo evidence for 5-lipoxygenase activation, Circulation, 85, 230, 10.1161/01.CIR.85.1.230 Ellis, 1976, Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that is TXA2, Science, 193, 1135, 10.1126/science.959827 Montrucchio, 2000, Role of platelet activating factor in cardiovascular pathophysiology, Physiol Rev, 80, 1669, 10.1152/physrev.2000.80.4.1669 Feuerstein, 1997, Platelet-activating factor and cardiac diseases: therapeutic potential for PAF inhibitors, J Lipid Cell Signalling, 15, 255, 10.1016/S0929-7855(96)00562-7 Abete, 1992, Age-related effects of platelet activating factor (PAF) in the isolated perfused rat heart, J Mol Cell Cardiol, 24, 1399, 10.1016/0022-2828(92)91081-F Tanniere, 1987, Direct effects of platelet-activating factor(PAF) on cardiac function in isolated guinea pig heart, Drug Rev Res, 11, 177, 10.1002/ddr.430110305 Clejan, 2002, Blood histamine is associated with coronary artery disease, cardiac events and severity of inflammation and atherosclerosis, J Cell Mol Med, 6, 583, 10.1111/j.1582-4934.2002.tb00456.x Takase, 1996, Arachidonic acid metabolites in acute myocardial infarction, Angiology, 47, 649, 10.1177/000331979604700703 Deliargyris, 2000, Sites of interleukin-6 release in patients with acute coronary syndromes and in patients with congestive heart failure, Am J Cardiol, 86, 913, 10.1016/S0002-9149(00)01121-8 Huang, 2003, Stress-induced interleukin-6 release in mice is mast cell-dependent and more pronounced in Apolipoprotein E knockout mice, Cardiovasc Res, 59, 241, 10.1016/S0008-6363(03)00340-7 Filipiak, 2003, Tryptase levels in patients with acute coronary syndromes: the potential new marker in unstable plaque?, Clin Cardiol, 26, 366, 10.1002/clc.4950260804 Deliargyris, 2005, Mast cell tryptase: a new biomarker in patients with stable coronary artery disease, Atherosclerosis, 178, 381, 10.1016/j.atherosclerosis.2004.09.008 Kaartinen, 1994, Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the prediction site of atheromatous rupture, Circulation, 90, 1669, 10.1161/01.CIR.90.4.1669 Kovanen, 1995, Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction, Circulation, 92, 1083, 10.1161/01.CIR.92.5.1084 Irani, 1992, Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells, Blood, 80, 3009, 10.1182/blood.V80.12.3009.3009 Valent, 1992, Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor (CSF)/kit ligand (KL) in long-term culture, Blood, 80, 2337–2245, 10.1182/blood.V80.9.2237.2237 Sakata, 1996, Elevation of plasma histamine concentration in the coronary circulation in patients with variant angina, Am J Cardiol, 77, 1121, 10.1016/S0002-9149(96)00147-6 Cuculo, 1998, Tryptase levels are elevated during spontaneous ischemic episodes in unstable angina but not after ergonovine test in variant angina, Cardiologia, 43, 189 Cipollone, 2003, Modulation of aspirin-insensitive eicosanoid biosynthesis by 6-methylprednisolone in unstable angina, Circulation, 107, 55, 10.1161/01.CIR.0000043260.82447.62 Fisher, 1986, Clinical observations on the pathophysiology and treatment of anaphylactic cardiovascular collapse, Anaesth Intensive Care, 14, 17, 10.1177/0310057X8601400105 Schummer, 2004, Anaphylactic shock: is vasopressin the drug of choice?, Anesthesiology, 101, 1025, 10.1097/00000542-200410000-00032 Heytman, 2004, Use of alpha-agonists for management of anaphylaxis occurring under anaesthesia: case studies and review, Anaesthesia, 59, 1210, 10.1111/j.1365-2044.2004.03968.x Fahmy, 1981, Hemodynamics, plasma histamine and catecholamine concentrations during an anaphylactoid reaction to morphine, Anesthesiology, 55, 329, 10.1097/00000542-198109000-00028 van der Linden, 1993, Anaphylactic shock after insect-sting challenge in 138 persons with a previous insect-sting reaction, Ann intern Med, 118, 161, 10.7326/0003-4819-118-3-199302010-00001 Hermann, 1992, Urinary excretion of angiotensin I, II, arginine vasopressin and oxytocin in patients with anaphylactoid reactions, Clin Exper Allergy, 22, 845, 10.1111/j.1365-2222.1992.tb02830.x Hanashiro, 1967, Anaphylactic shock in man: report of two cases with detailed hemodynamics and metabolic studies, Arch Intern Med, 119, 129, 10.1001/archinte.1967.00290200053001 Brown, 2005, Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis, Curr Opin Allergy Immunol, 5, 359, 10.1097/01.all.0000174158.78626.35 Wittstein, 2005, Neurohumoral features of myocardial stunning due to sudden emotional stress, N Engl J Med, 352, 539-538, 10.1056/NEJMoa043046 Felix, 1990, Systemic anaphylaxis separation of cardiac reactions from respiratory and peripheral vascular events, Res Exp Med, 190, 239, 10.1007/BF00000029 Levi, 1988, Cardiac anaphylaxis: models, mediators, mechanisms, and clinical considerations, vol. 1, 93 Zavecz, 1977, Separation of primary and secondary cardiovascular events in systemic anaphylaxis, Circ Res, 40, 15, 10.1161/01.RES.40.1.15 Vigorito, 1986, Effect of activation of H1 receptor on coronary hemodynamics in man, Circulation, 73, 1175, 10.1161/01.CIR.73.6.1175 Bristow, 1982, Histamine and the human heart: the other receptor system, Am J Cardiol, 49, 249, 10.1016/0002-9149(82)90298-3 Mitsuhata, 1995, Role of nitric oxide in anaphylactic shock, J Clin Immunol, 15, 277, 10.1007/BF01541317 Palmer, 1987, Nitric oxide release accounts for the biological activity of endothelium derived relaxing factor, Nature, 327, 524, 10.1038/327524a0 Kemp, 2002, Anaphylaxis: a review of causes and mechanisms, J Allergy Clin Immunol, 110, 341, 10.1067/mai.2002.126811 Mink, 1999, Role of autacoids in cardiovascular collapse in anaphylactic shock in anesthetized dogs, Cardiovasc Res, 43, 173, 10.1016/S0008-6363(99)00073-5 Hofstra, 2003, Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells, J Pharmacol Exp Ther, 305, 1212, 10.1124/jpet.102.046581 O'Reilly, 2002, Identification of a histamine H4 receptor on human eosinophil-role in eosinophil chemotaxis, J Recept Signal Transduct Res, 22, 431, 10.1081/RRS-120014612 Ling, 2004, Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation, Brit J Pharmacol, 142, 161, 10.1038/sj.bjp.0705729 Gantner, 2002, Histamine h(4) and h(2) receptors control histamine-induced interleukin-16 release from human CD8(+) t cells, J Pharmacol Exp Ther, 303, 300, 10.1124/jpet.102.036939 Bousquet, 1990, Eosinophilic inflammation in asthma, N Engl J Med, 323, 1033, 10.1056/NEJM199010113231505 Macfarlane, 2000, Basophils, eosinophils and mast cells in atopic and nonatopic asthma and in late-phase allergic reactions in the lung and skin, J Allergy Clin Immunol, 105, 99, 10.1016/S0091-6749(00)90184-2 Burks, 1999, Peanut-induced anaphylactic reactions, Int Arch Allergy Immunol, 119, 165, 10.1159/000024191 Brown, 2004, Insect sting anaphylaxis; prospective evaluation of treatment with intravenous adrenaline and volume resuscitation, Emerg Med J, 21, 149, 10.1136/emj.2003.009449 Laxenaire, 2001, Anaphylaxis during anaesthesia: results of a two-year survey in France, Br J Anaesth, 87, 549, 10.1093/bja/87.4.549 Helbling, 2004, Incidence of anaphylaxis with circulatory symptoms: a study over a 3-year period comprising 940000 inhabitants of the Swiss Canton Bern, Clin Exp Allergy, 34, 285, 10.1111/j.1365-2222.2004.01882.x Pfister, 1950, Acute myocardial infarction during a prolonged allergic reaction to penicillin, Am Heart J, 40, 945, 10.1016/0002-8703(50)90191-8 Johnston, 2003, Adrenaline given outside the context of life threatening allergic reactions, BMJ, 326, 589, 10.1136/bmj.326.7389.589 Saadeh, 2001, Case report: acute myocardial infarction complicating a viper bite, Am J Trop Med Hyg, 64, 280, 10.4269/ajtmh.2001.64.280 Criqui, 1987, IgE and cardiovascular disease. Results from a population-based study, Am J Med, 82, 964, 10.1016/0002-9343(87)90159-8 Masini, 1994, Platelet aggregation and histamine release by immunological stimuli, Immunopharmacology, 28, 19, 10.1016/0162-3109(94)90035-3 Masini, 1997, Platelet aggregation and platelet histamine release by immunological stimulation in atopic patients: modulation by nitric oxide, Infamm Res, 46, S81, 10.1007/s000110050096 Mori, 1997, Vasospastic angina induced by nonsteroidal anti-inflammatory drugs, Clin Cardiol, 20, 656, 10.1002/clc.4960200713 Brown, 2004, Clinical features and severity grading of anaphylaxis, J Allergy Clin Immunol, 114, 371, 10.1016/j.jaci.2004.04.029 Ginsburg, 1981, Histamine provocation of clinical coronary artery spasm: implications concerning pathogenesis of variant angina pectoris, Am Heart J, 102, 819, 10.1016/0002-8703(81)90030-2 Sebaldt, 1990, Inhibition of eicosanoid biosynthesis by glucocorticoid in humans, Proc Natl Acad Sci U S A, 87, 6974, 10.1073/pnas.87.18.6974 Theoharides, 2004, Mast cells and mast cell mediators as targets of dietary supplements, Ann Allergy Asthma Immunol, 93, S24, 10.1016/S1081-1206(10)61484-6 Leung, 2003, Effect of anti-IgE therapy in patients with peanut allergy, N Engl J Med, 348, 986, 10.1056/NEJMoa022613 Finkelman, 2005, Molecular mechanisms of anaphylaxis: lessons from studies with murine models, J Allergy Clin Immunol, 115, 449, 10.1016/j.jaci.2004.12.1125 Nemmar, 2004, Pharmacological stabilization of mast cells abrogates late thrombotic events induced by diesel exhaust particles in hamsters, Circulation, 110, 1670, 10.1161/01.CIR.0000142053.13921.21